Biological monitoring for industrial exposure to tetraalkyl lead.

An evaluation of the Chamber Works control program was made relative to the 1967 Threshold Limit Value (ACGIH) for tetraalkyl lead compounds. Results from fixed station samplers throughout the manufacturing areas had not correlated well with routine medical examinations and urinary excretion levels for lead. Similarly there was no correlation of fixed station results with urinary excretion rates.